Antioxidant therapy alleviates oxidative stress by androgen deprivation and prevents conversion from androgen dependent to castration resistant prostate cancer.

Shiota, Masaki; Song, Yoohyun; Takeuchi, Ario; Yokomizo, Akira; Kashiwagi, Eiji; Kuroiwa, Kentaro; Tatsugami, Katsunori; Uchiumi, Takeshi; Oda, Yoshinao; Naito, Seiji

Shiota, Masaki; Song, Yoohyun; Takeuchi, Ario; Yokomizo, Akira; Kashiwagi, Eiji; Kuroiwa, Kentaro; Tatsugami, Katsunori; Uchiumi, Takeshi; Oda, Yoshinao; Naito, Seiji.

Affiliation

Shiota M; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

J Urol ; 187(2): 707-14, 2012 Feb.

Article in En | MEDLINE | ID: mdl-22177207

Subject(s)

Oxidative Stress; Prostatic Neoplasms/metabolism; Androgen Antagonists/therapeutic use; Animals; Antioxidants/therapeutic use; Drug Resistance, Neoplasm; Humans; Male; Mice; Neoplasm Transplantation; Nuclear Proteins/biosynthesis; Prostatic Neoplasms/drug therapy; Receptors, Androgen/biosynthesis; Tumor Cells, Cultured; Twist-Related Protein 1/biosynthesis; Y-Box-Binding Protein 1/biosynthesis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Oxidative Stress Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Year: 2012 Type: Article

Fulltext

XML

PubMed Links

Search on Google